tiprankstipranks

Ross Macdonald Insider Profile

4 Followers
Ross Macdonald, Managing Director & Chief Executive Officer at Cynata Therapeutics Limited, holds 2.13M shares in Cynata Therapeutics Limited (Ticker: CYYNF), holds 540.00K shares in Respiri Limited (Ticker: RSHUF). Most recently, Ross Macdonald Bought ― shares of Cynata Therapeutics Limited on Jun 01, 2023 for an estimated value of 12.00K.
tipranks
Ross  Macdonald

Ross Macdonald
Cynata Therapeutics Limited (CYYNF)
Managing Director & Chief Executive Officer

Ranked #20,358 out of 98,743 Corporate Insiders

Profitable Transactions

33%
1 out of 3 Profitable Transactions

Average Return

+38.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$249K
93.93%
6.07%
A breakdown of Ross Macdonald's holdings

Insider Roles

Cynata Therapeutics Limited
(CYYNF)
Managing Director & Chief Executive Officer
Respiri Limited
(RSHUF)
Director
Roles that Ross Macdonald holds in companies

Most Profitable Insider Trade

Stock:
Cynata Therapeutics Limited
(CYYNF)
Rating:Informative Buy
Date:Apr 03, 2017 - Apr 03, 2018
Return:+176.00%
The most profitable trade made by Ross Macdonald

Ross Macdonald's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Cynata Therapeutics Limited
Jun 01, 2023
Managing Director & Chief Executive Officer
Informative Buy
12.00K
$233.84K
Respiri Limited
Dec 18, 2012
Director
Informative Buy
$15.12K
List of latest transactions for each holding click on a transaction to see Ross Macdonald's performance on stock

Ross Macdonald insider profile FAQ

What is the percentage of profitable transactions made by Ross Macdonald?
The percentage of profitable transactions made by Ross Macdonald is 33%.
    What is the average return per transaction made by Ross Macdonald?
    The average return per transaction made by Ross Macdonald is 38.30%.
      What stocks does Ross Macdonald hold?
      Ross Macdonald holds: CYYNF, RSHUF stocks.
        What was Ross Macdonald’s latest transaction?
        Ross Macdonald latest transaction was an Informative Buy of $12.00K.
          What was Ross Macdonald's most profitable transaction?
          Ross Macdonald’s most profitable transaction was an Informative Buy of CYYNF stock on April 3, 2017. The return on the trade was 176.00%.
            What is Ross Macdonald's role in Cynata Therapeutics Limited?
            Ross Macdonald's role in Cynata Therapeutics Limited is Managing Director & Chief Executive Officer.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.